SLC7A11/xCT Polyclonal antibody

SLC7A11/xCT Polyclonal Antibody for WB, IF-P, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

mouse, rat

Applications

WB, IF-P, ELISA

Conjugate

Unconjugated

Cat no : 32384-1-AP

Print datasheet

Synonyms

sut, Subtle gray protein, Solute carrier family 7 member 11, Slc7a11, Cystine/glutamate transporter



经过测试的应用

Positive WB detected inmouse brain tissue, mouse kidney tissue, mouse stomach tissue, rat brain tissue, rat liver tissue
Positive IF-P detected inmouse eye tissue

推荐稀释比

ApplicationDilution
Western Blot (WB)WB : 1:500-1:3000
Immunofluorescence (IF)-PIF-P : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

32384-1-AP targets SLC7A11/xCT in WB, IF-P, ELISA applications and shows reactivity with mouse, rat samples.

Tested Applications WB, IF-P, ELISA Application Description
Tested Reactivity mouse, rat
Immunogen SLC7A11/xCT fusion protein Ag38215 种属同源性预测
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Full Name solute carrier family 7 (cationic amino acid transporter, y+ system), member 11
Synonyms sut, Subtle gray protein, Solute carrier family 7 member 11, Slc7a11, Cystine/glutamate transporter
Calculated Molecular Weight55 kDa
Observed Molecular Weight70 kDa
GenBank Accession NumberNM_011990
Gene Symbol Slc7a11
Gene ID (NCBI) 26570
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity Purification
UNIPROT IDQ9WTR6
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

SLC7A11 (also known as xCT) is a membrane transporter involved in cysteine uptake. It promotes glutathione synthesis through cystine uptake and the concomitant release of glutamate. This, in turn, protects cells from oxidative stress, maintains cellular redox balance, and prevents cell death induced by lipid peroxidation. SLC7A11 has been identified as a potential target for cancer therapeutics. It is overexpressed in multiple malignant tumors and is closely associated with the growth, prognosis, metastasis, and treatment response of various cancers including lung cancer.

实验方案

Product Specific Protocols
WB protocol for SLC7A11/xCT antibody 32384-1-APDownload protocol
IF protocol for SLC7A11/xCT antibody 32384-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols